Hybrigenics Services announce the launch of its new service:
an in-yeast compound profiling service that aims to identify the protein targets of a small molecule
This new service, based on the yeast 3-hybrid technology, allows for in-vivo detection of protein-ligand interactions.
It tackles crucial issues in drug discovery and development such as target identification, off-target side effects and toxicity and drug repositionning.



